on by climate changes and allowed them to coalesce, potentially leading to the eventual regime shifts and collapses observed in megafaunal ecosystems. The lack of evidence for larger-scale ecological regime shifts during earlier periods of the Glacial (i.e., >45 ka) when interstadial events were common, but modern humans were not, supports a synergistic role for humans in exacerbating the impacts of climate change and extinction in the terminal Pleistocene events.
18 O record is provided in (20) and also lodged on the Paleoclimatology Database (National Oceanic and Atmospheric Administration dataset ID: noaa-icecore-19015). The previously published radiocarbon data, with original references, is presented in (20) . A.C. and C.T. conceived and performed research; A.C., C.J.A.B., C.T., and B.W.B. designed methods and performed analysis; A.C. and C.T. wrote the paper with input from all authors. 5 ‡ Dina Averbuch, 6 ‡ Macarena Lagos, 7, 8 ‡ Mohammed Alzahrani, 9 ‡ Saleh Al-Muhsen, 9 ,10 ‡ Rabih Halwani, 10 Cindy S. Ma, 3, 4 Natalie Wong, 3 Claire Soudais, 11 Lauren A. Henderson, 12 Hiyam Marzouqa, 13 Jamal Shamma, 13 Marcela Gonzalez, 7 Rubén Martinez-Barricarte, 1 Chizuru Okada, 1 Danielle T. Avery, 3 Daniela Latorre, 5 Caroline Deswarte, 14, 15 Fabienne Jabot-Hanin, 14, 15 Egidio Torrado, 16 § Jeffrey Fountain, 16 || Aziz Belkadi, 14, 15 Yuval Itan, 1 Bertrand Boisson, 1 Mélanie Migaud, 14, 15 Cecilia S. Lindestam Arlehamn, 17 Alessandro Sette, 17 Sylvain Breton, 18 James McCluskey, 19 Jamie Rossjohn, 20, 21, 22 Jean-Pierre de Villartay, 23 Despina Moshous, 23, 24 Sophie Hambleton, 25 Sylvain Latour, 26 Peter D. Arkwright, 27 Capucine Picard, 1, 14, 15, 24, 28 Olivier Lantz, 11 Dan Engelhard, 6 Masao Kobayashi, 2 Laurent Abel, 1, 14, 15 Human inborn errors of immunity mediated by the cytokines interleukin-17A and interleukin-17F (IL-17A/F) underlie mucocutaneous candidiasis, whereas inborn errors of interferon-g (IFN-g) immunity underlie mycobacterial disease. We report the discovery of bi-allelic RORC loss-of-function mutations in seven individuals from three kindreds of different ethnic origins with both candidiasis and mycobacteriosis. The lack of functional RORg and RORgT isoforms resulted in the absence of IL-17A/F-producing T cells in these individuals, probably accounting for their chronic candidiasis. Unexpectedly, leukocytes from RORg-and RORgT-deficient individuals also displayed an impaired IFN-g response to Mycobacterium. This principally reflected profoundly defective IFN-g production by circulating gd T cells and CD4 + CCR6 + CXCR3 + ab T cells. In humans, both mucocutaneous immunity to Candida and systemic immunity to Mycobacterium require RORg, RORgT, or both.
I
nborn errors of human interleukin-17A and interleukin-17F (IL-17A/F) or interferon-g (IFN-g) immunity are each associated with a specific set of infections. Inborn errors of IL-17A/F underlie chronic mucocutaneous candidiasis (CMC), which is characterized by infections of the skin, nails, and oral and genital mucosae with Candida albicans, typically in the absence of other infections. Five genetic etiologies of CMC have been reported, with mutations in five genes (1, 2) . Inborn errors of IFN-g underlie Mendelian susceptibility to mycobacterial disease (MSMD), which is characterized by selective susceptibility to weakly pathogenic mycobacteria, such as Mycobacterium bovis Bacille CalmetteGuérin (BCG) vaccines and environmental mycobacteria. Eighteen genetic etiologies of MSMD have been reported, involving mutations of nine genes (3, 4) . Only a few patients display both candidiasis and mycobacteriosis, including some patients with IL-12p40 and IL-12Rb1 deficiencies, which impair IFN-g immunity in all patients and IL-17A/F immunity in some patients (4) . We studied seven patients from three unrelated consanguineous families with this unusual combination of infectious diseases but no known genetic disorder. A Palestinian child (Fig. 1A , Kindred A, patient P1; see also supplementary text) died at the age of 6 years from disseminated BCG disease. Two other children (P2 and P3) in Kindred A had similar clinical presentations but survived and are now 7 and 4 years old, respectively. A 6-yearold Chilean child (Fig. 1A, Kindred B, P4 ; see also supplementary text) had disseminated BCG infection at age 16 months. Finally, three siblings from Saudi Arabia (Fig. 1A , Kindred C, P5, P6, and P7; see also supplementary text), ages 9, 6, and 3 years, had mycobacterial diseases caused by BCG in two children and by M. tuberculosis in the third. Six of the seven patients also had mucocutaneous candidiasis of varying severity (table S1) .
Bi-allelic RORC mutations
We combined whole-exome sequencing and genome-wide linkage (GWL) analysis to search for homozygous genetic lesions in the three probands (P1, P4, and P6) ( fig. S1 ). We identified a homozygous C/T mutation in the RORC gene in P1, P2, and P3, resulting in a missense Ser 38 →Leu 38 (S38L) substitution in the RORg isoform or a S17L substitution in the RORgT isoform (Fig. 1, A and B, and fig. S2 ). In P4, we identified a homozygous RORC C/T mutation converting the Gln 329 (Q329) residue of RORg (or Q308 in RORgT) into a stop codon (Fig. 1, A and B, and fig. S2 ). In P5, P6, and P7, we identified a homozygous C/T mutation converting the Q441 residue of RORg (or Q420 in RORgT) into a stop codon (Fig. 1, A and  B, and fig. S2 ). In each kindred, all unaffected family members were either heterozygous or homozygous for the wild-type (WT) allele (Fig. 1A  and fig. S2 ). The familial segregation of these mutant RORC alleles was therefore consistent with an autosomal recessive (AR) pattern of inheritance. There were no other genes mutated in the three kindreds among the 173 genes on the 6.87-Mb interval linked with disease (maximum LOD score 6.35). The S17L mutation affects a strictly conserved residue of the DNA binding domain of RORgT (Fig. 1B) and is predicted to be damaging by multiple software algorithms (5) . The Q308X and Q420X (X signifies a stop codon) nonsense mutations are predicted to result in truncated proteins lacking part of the ligand-binding domain (Fig. 1B) . The Q308X and Q420X alleles were not found in the National Center for Biotechnology Information, Ensembl, Exome Aggregation Consortium (ExAC), and dbSNP databases; in our own in-house database of more than 3000 exomes; or in 1052 controls from 52 ethnic groups in the CEPH-HGD panel, indicating that they were very rare variants, possibly exclusive to these two kindreds. There were no nonsense or frameshift mutations affecting isoform 2 (RORgT) in these databases. The S17L allele was found in one heterozygous individual of the ExAC database, indicating that its frequency is less than 10 . We therefore hypothesized that the bi-allelic RORC mutations found in these three kindreds were disease-causing.
Complete RORg and RORgT deficiency
In mice and humans, the RORg and RORgT isoforms are generated by transcription from different start sites (6) (7) (8) (9) (10) (Fig. 1B) . Both molecules are transcription factors, but they have different expression patterns in inbred mice: RORg is ubiquitous, whereas RORgT is restricted to leukocytes (10) . RORgT plays an important role in T cell development and function in mice (11, 12) . Animals lacking only RORgT apparently have the same immunological phenotype as those lacking both isoforms (10) . We first assessed the effect of RORC mutations by transiently expressing WT and mutant RORgT and RORg in human embryonic kidney 293T (HEK293T) cells in the presence and absence of stimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin. We detected both the WT and S17L RORgT proteins at the expected molecular mass of 56 kD (Fig. 1C) . The Q308X and Q420X RORgT mutant proteins had molecular weights consistent with truncation at residues 308 and 420, respectively (Fig. 1C) . Similar results were obtained upon expression of RORg ( fig. S3) . We then performed an electrophoretic mobility shift assay (EMSA) to assess the ability of the mutant RORgT and RORg isoforms to respectively bind to RORE-2 and RORE-1, the consensus binding sites in the promoter of IL17A (fig. S3 ). The three mutations abolished DNA binding of RORgT to RORE-2 ( Fig. 1C) and of RORg to RORE-1 ( fig. S3 ), but not by disrupting the nuclear localization of the protein ( fig. S3 ). Each mutation resulted in the loss of IL17A promoter activation by RORgT (Fig. 1D) or RORg ( fig. S4 ). Thus, each mutant allele was associated with a complete loss of function of the two encoded protein isoforms, identifying these patients as cases of human AR complete RORg/RORgT deficiency (hereafter referred to as RORgT deficiency). . 2D and table  S2 ). These patients did not, therefore, have T cell deficiency [also known as "combined" immunodeficiency (CID)], consistent with their lack of broad infectious and autoimmune phenotypes (21) . Finally, the frequencies of circulating gd T cells were normal (table S2) . Overall, these RORC -/-patients displayed the general immunological features characteristic of Rorc -/-mice (11, 12, 14, 22, 23) .
Broad immunological phenotype
These studies also revealed that the development of MAIT and other Va7.2 + T cells is critically dependent on RORgT, which had been predicted but not shown in mice. No infectious phenotype can be unambiguously assigned to any of these individual immunological anomalies.
Abolished production of IL-17A/F
Given the critical role of murine RORgT in generating IL-17A/F-and IL-22-producing lymphocytes [including ILC3, gd T cells, and T H 17 cells (11, 13, 24) ] and the finding that patients with compromised IL-17A/F immunity are susceptible to mucocutaneous candidiasis (1), we assessed the development and function of IL-17A/F-producing lymphocytes in the patients. Circulating ILC3 were too few to assess their production of IL-17. CD3 + T cells from RORC -/-patients displayed a severe impairment in the production of IL-17A, IL-17F, and IL-22, at both the mRNA ( fig. S8 ) and the protein level (Fig. 3A) , after polyclonal stimulation. CD4 + ab T cells are a major source of IL-17A/F (9). Memory (CD45RA
patients produced much less IL-17A, IL-17F, and IL-22 than WT and heterozygous controls (Fig. 3B) . Whole-cell lysates were obtained and subjected to Western blotting (lower panel), and nuclear lysates were subjected to EMSA with a 32 P-labeled RORE-2 probe derived from the IL17A promoter sequence (upper panel). GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (D) IL17A reporter plasmids, the pRL-SV40 vector, and WTor mutant RORC plasmid were used to transfect HEK293T cells. After 24 hours, cells were stimulated with PMA and ionomycin as in (C) and then subjected to luciferase assays. Experiments were performed in triplicate, and IL17A promoter activity is expressed as fold induction relative to mock-transfected cells. *P < 0.05 versus WT controls; two-tailed Mann-Whitney tests with Bonferroni correction. Error bars denote SEM.
In contrast, the memory CD4 + T cells from these patients produced large amounts of IL-4, IL-5, and IL-13 ( fig. S8) (Fig. 3E ). IFN-g was also reduced, but large amounts of IL-4 were secreted, serving as a control (Fig. 3E) . Finally, Herpesvirus saimiri-transformed CD4 + ab T cells from RORC -/-patients showed abolished induction of RORC (Fig. 4A) and IL17A (Fig.  4B ), but not IFNG serving as a control (fig. S10 ).
The defect in IL17A induction could be rescued by retroviral transduction with WT RORC (Fig. 4B) .
Collectively, these data demonstrate a profound diminution of IL-17A/F and IL-22 production by all leukocytes tested in RORC -/-patients. As CMCcausing germline mutations have previously been identified in IL17F, IL17RA, IL17RC, and ACT1 (1, 2, 26), we conclude that impaired IL-17A/F immunity in RORC -/-patients accounts for their development of CMC. Human IL-17A/F-producing ILC3, gd T cells, and ab T cells, or any of their subsets, may individually or collectively confer protection against Candida.
Selective defect in IFN-g production
We then investigated the cellular mechanism underlying the patients' surprising susceptibility to mycobacteria. The patients did not display chronic granulomatous disease or severe CID, which can underlie BCG disease ( the patients produced IFN-g normally (fig. S10) . Overall, and in contrast to the IL-17A/F defect, RORgT deficiency does not impair IFN-g secretion in conditions of polyclonal stimulation. We next assessed Mycobacterium-specific IFN-g responses from whole blood (Fig. 5A) or PBMCs (Fig. 5B ) of RORC -/-patients, heterozygous family members, and healthy controls. The patients' cells produced very little IFN-g in response to treatment with BCG plus IL-12 (Fig. 5, A and B) . This defect was as profound as that seen in patients with IL-12Rb1 deficiency (27) . (Fig. 5D) . The normal proliferation and cytokine production of other CD4 + memory T cell subsets in response to Candida and Mycobacterium ( fig. S17 ) and to irrelevant viral stimuli ( fig. S18 ) indicate a selective RORgTdependent functional defect in Mycobacteriumspecific CD4 + CCR6
+ ab T cells. Although we did not purify and test T H 1* cells, they were present in normal proportions in the patients ( fig. S9 ), implying that they are functionally defective for IFN-g production upon Mycobacterium stimulation. Collectively, these data suggest that mycobacterial diseases in RORC -/-patients may result from the poor production of IFN-g by gd T cells, CCR6 + CXCR3 + CD4 + ab T H 1* cells, or both in response to mycobacteria. IFN-g treatment may therefore be beneficial for RORC -/-patients. This combined defect probably also accounts for mycobacterial disease in severe combined immunodeficient patients, as patients with various forms of CID are normally resistant to BCG (27, 33) . Finally, the lack of MAIT and type 1 NKT cells, reduction in ILC3, and possibly the absence of other lymphocytes not analyzed using blood samples (e.g., LTi) may aggravate the mycobacterial phenotype of RORC -/-patients.
Conclusion
Collectively, these data demonstrate that human RORC plays a surprising dual role in host defense. These findings are clinically, immunologically, and genetically robust, as they were consistent in seven patients from three ethnic groups, homozygous for three different RORC mutations that are loss-of-function for both isoforms. Although the two infectious phenotypes are purely recessive, some immunological phenotypes showed codominant or dominant inheritance. The mild T cell lymphopenia, small thymus, lack of palpable axillary and cervical lymph nodes, and absence of MAIT and type 1 NKT cells in RORC -/-patients were consistent with the phenotype of Rorc -/-mice (table S3) . Likewise, impaired IL-17A/F immunity was predicted to account for impaired protection against Candida albicans (35), as Rorc is the master gene controlling T H 17 differentiation in inbred mice (11) , and mutations affecting human IL-17A/F immunity underlie isolated CMC (1, 26, 36) . The IL-17A/F defect therefore underlies CMC in RORgT-deficient patients, probably but not necessarily because of T cells, as other cells can produce these cytokines in healthy individuals. We expected these patients to be susceptible to candidiasis, but their susceptibility to mycobacterial disease and its severity were unanticipated. This phenotype does not seem to be human-specific, as we also found that mice deficient for Rorc (14) are susceptible to mycobacterial infection ( fig. S19) . Our data conclusively demonstrate that human RORC plays an indispensable role in the induction of IFN-g-dependent antimycobacterial systemic immunity. The mechanism underlying disease in these patients probably involves an impairment of the induction of IFN-g production by gd T cells, CCR6 W eyl fermions have long been known in quantum field theory, but have not been observed as a fundamental particle in nature (1-3). Recently, it was understood that a Weyl fermion can emerge as a quasiparticle in certain crystals, Weyl fermion semimetals . Despite being a gapless metal, a Weyl semimetal is characterized by topological invariants, broadening the classification of topological phases of matter beyond insulators. Specifically, Weyl fermions at zero energy correspond to points of bulk band degeneracy, Weyl nodes, which are associated with a chiral charge that protects gapless surface states on the boundary of a bulk sample. These surface states take the form of Fermi arcs connecting the projection of bulk Weyl nodes in the surface Brillouin zone (BZ) (6) . A band structure like the Fermi arc surface states would violate basic band theory in an isolated two-dimensional (2D) system and can only arise on the boundary of a 3D sample, providing a dramatic example of the bulk-boundary correspondence in a topological phase. In contrast to topological insulators where only the surface states are interesting (21, 22) , a Weyl semimetal features unusual band structure in the bulk and on the surface. The Weyl fermions in the bulk are predicted to provide a condensedmatter realization of the chiral anomaly, giving rise to a negative magnetoresistance under parallel electric and magnetic fields, unusual optical conductivity, nonlocal transport, and local nonconservation of ordinary current (5, (12) (13) (14) (15) (16) . At the same time, the Fermi arc surface states are predicted to show unconventional quantum oscillations in magneto-transport, as well as unusual quantum interference effects in tunneling spectroscopy (17) (18) (19) . The prospect of the realization of these phenomena has inspired much experimental and theoretical work .
Here we report the experimental realization of a Weyl semimetal in a single crystalline material, tantalum arsenide (TaAs). Using the combination of the vacuum ultraviolet (low-photon-energy) and soft x-ray (SX) angle-resolved photoemission spectroscopy (ARPES), we systematically and differentially study the surface and bulk electronic structure of TaAs. Our ultraviolet (low-photonenergy) ARPES measurements, which are highly surface sensitive, demonstrate the existence of the Fermi arc surface states, consistent with our band calculations presented here. Moreover, our SX-ARPES measurements, which are reasonably bulk sensitive, reveal the 3D linearly dispersive bulk Weyl cones and Weyl nodes. Furthermore, by combining the low-photon-energy and SX-ARPES data, we show that the locations of the projected bulk Weyl nodes correspond to the terminations of the Fermi arcs within our experimental resolution. These systematic measurements demonstrate TaAs as a Weyl semimetal.
The material system and theoretical considerations
Tantalum arsenide is a semimetallic material that crystallizes in a body-centered tetragonal lattice system (Fig. 1A) (23) . The lattice constants are a = 3.437 Å and c = 11.656 Å, and the space group is I4 1 md (#109, C 4v ), as consistently reported in previous structural studies ( [23] [24] [25] . The crystal consists of interpenetrating Ta and As sublattices, where the two sublattices are shifted by ð a 2 ; a 2 ; dÞ, d≈ c 12 . Our diffraction data match well with the lattice parameters and the space group I4 1 md (26). The scanning tunneling microscopic (STM) topography (Fig. 1B) clearly resolves the (001) square lattice without any obvious defect. From the topography, we obtain a lattice constant a = 3.45 Å. Electrical transport measurements on TaAs confirmed its semimetallic transport properties and reported negative magnetoresistance, suggesting the anomalies due to Weyl fermions (23) .
We discuss the essential aspects of the theoretically calculated bulk band structure (9, 10) that predicts TaAs as a Weyl semimetal candidate. Without spin-orbit coupling, calculations (9, 10) show that the conduction and valence bands interpenetrate (dip into) each other to form four 1D line nodes (closed loops) located on the k x and k y planes (shaded blue in Fig. 1, C and E) . Upon the inclusion of spin-orbit coupling, each line node loop is gapped out and shrinks into six Weyl nodes that are away from the k x ¼ 0 and k y ¼ 0 mirror planes (Fig. 1E, small filled circles) . In our calculation, in total there are 24 bulk Weyl cones (9, 10), all of which are linearly dispersive and are associated SCIENCE sciencemag.org 7 AUGUST 2015 • VOL 349 ISSUE 6248
